The DOI matches its Crossref record; 212 of the 212 references it cites were found in a registry or an index.
Androgen Signaling in Prostate Cancer
Open accessAbstract
The androgen-signaling axis plays a pivotal role in the pathogenesis of prostate cancer. Since the landmark discovery by Huggins and Hodges, gonadal depletion of androgens has remained a mainstay of therapy for advanced disease. However, progression to castration-resistant prostate cancer (CRPC) typically follows and is largely the result of restored androgen signaling. Efforts to understand the mechanisms behind CRPC have revealed new insights into dysregulated androgen signaling and intratumoral androgen synthesis, which has ultimately led to the development of several novel androgen receptor (AR)-directed therapies for CRPC. However, emergence of resistance to these newer agents has also galvanized new directions in investigations of prereceptor and postreceptor AR regulation. Here, we review our current understanding of AR signaling as it pertains to the biology and natural history of prostate cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–212 of 212
Unraveling the Complexities of Androgen Receptor Signaling in Prostate Cancer Cells
Heemers, H. V., & Tindall, D. J. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.03.009 · Cited by 32
Self-citationSteroid Receptors Aplenty in Prostate Cancer
Sharifi, N. (2014) · New England Journal of Medicine · doi:10.1056/nejmcibr1315706 · Cited by 31
Self-citationFiandalo, M. V., Wilton, J. H., & Mohler, J. L. (2014) · International Journal of Biological Sciences · doi:10.7150/ijbs.8780 · Cited by 31
Clinical Relevance of Androgen Receptor Splice Variants in Castration-Resistant Prostate Cancer
Maughan, B. L., & Antonarakis, E. S. (2015) · Current Treatment Options in Oncology · doi:10.1007/s11864-015-0375-z · Cited by 29
A FOXA1-binding enhancer regulates Hoxb13 expression in the prostate gland
McMullin, R. P., Dobi, A., Mutton, L. N., Orosz, A., Maheshwari, S., Shashikant, C. S., & Bieberich, C. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902001107 · Cited by 29
Thirumalai, A., Cooper, L. A., Rubinow, K. B., Amory, J. K., Lin, D. W., Wright, J. L., Marck, B. T., Matsumoto, A. M., & Page, S. T. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1483 · Cited by 27
Heemers, H. V., Schmidt, L. J., Kidd, E., Raclaw, K. A., Regan, K. M., & Tindall, D. J. (2010) · The Prostate · doi:10.1002/pros.21130 · Cited by 23
Self-citationProstate cancer—from steroid transformations to clinical translation
Chang, K., & Sharifi, N. (2012) · Nature Reviews Urology · doi:10.1038/nrurol.2012.175 · Cited by 22
Self-citation5α-Reductase: History and Clinical Importance
Marks, L. S. (2004) · Reviews in urology · Cited by 20
Heemers, H. V. (2014) · International Journal of Biological Sciences · doi:10.7150/ijbs.8479 · Cited by 17
Self-citationBui, A. T., Huang, M., Havard, M., Laurent-Tchénio, F., Dautry, F., & Tchénio, T. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1310345 · Cited by 15
Hormone Whodunit: Clues for Solving the Case of Intratumor Androgen Production
Knudsen, K. E. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1188 · Cited by 4
Cited by
Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer
Smith, M. R., Saad, F., Chowdhury, S., Oudard, S., Hadaschik, B. A., Graff, J. N., Olmos, D., Mainwaring, P. N., Lee, J. Y., Uemura, H., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1715546 · Cited by 1,344
Targeting transcription factors in cancer — from undruggable to reality
Bushweller, J. H. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0196-7 · Cited by 919
Hormonal Therapy for Prostate Cancer
Desai, K., McManus, J. M., & Sharifi, N. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab002 · Cited by 447
Self-citationEpidemiology and genomics of prostate cancer in Asian men
Zhu, Y., Mo, M., Wei, Y., Wu, J., Pan, J., Freedland, S. J., Zheng, Y., & Ye, D. (2021) · Nature Reviews Urology · doi:10.1038/s41585-021-00442-8 · Cited by 287
Tumor cell plasticity in targeted therapy-induced resistance: Mechanisms and new strategies
Shi, Z.-D., Pang, K., Wu, Z.-X., Dong, Y., Hao, L., Qin, J.-X., Wang, W., Chen, Z.-S., & Han, C.-H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01383-x · Cited by 256
Metadata
- Authors
- Dai, C., Heemers, H., & Sharifi, N.
- Venue
- Cold Spring Harbor Perspectives in Medicine
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2017-04-07
- Volume
- 7
- Issue
- 9
- Pages
- a030452
- ISSN
- 2157-1422 (ISSN-L)
- OpenAlex
- W2605070587
- Cited by
- 406
- References
- 212
- Type
- posted content
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.